Legal Opinion
Wyeth v. Lupin Ltd.
District Court, D. Maryland
Decided September 11, 2007No. Civil WDQ-07-0632PublishedCited by 6 opinions
1Opinion of the Court
MEMORANDUM OPINION
WILLIAM D. QUARLES, JR., District Judge.
Wyeth sued Lupin Ltd. (“Lupin”) and Lupin Pharmaceuticals, Inc. (“LPI”) for patent infringement and inducement of infringement. Pending are LPI’s motion to dismiss and Wyeth’s motion for leave to file a surreply. For the reasons discussed below, both motions will be denied.
I. Background
Wyeth owns Patents 6,274,171 Bl; 6,403,120 Bl; and 6,419,958 B2, all of which are entitled “Extended Release Formulation uf Venlafaxine Hydrochloride.” Wyeth uses the patents to manufacture and distribute EFFEXOR® XR Capsules, an extended release dosage…
2Cases cited18 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Papasan v. AllainSupreme Court of the United States · 1986
- Portia Bass v. E.I. Dupont De Nemours & Company, Portia Bass v. E.I. Dupont De Nemours & Company, Portia Bass v. E.I. Dupont De Nemours & CompanyCourt of Appeals for the Fourth Circuit · 2003
- Daniel L. Veney v. T v. Wyche Darnley R. Hodge, SuperintendentCourt of Appeals for the Fourth Circuit · 2002
- Khoury v. MeserveDistrict Court, D. Maryland · 2003
13 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- AstraZeneca UK Ltd. v. Aurobindo Pharma Ltd.Court of Appeals for the Federal Circuit · 2012
- Cephalon, Inc. v. Watson Pharmaceuticals, Inc.District Court, D. Delaware · 2009
- Galderma Labs., L.P. v. Teva Pharm. USA, Inc.District Court, N.D. Texas · 2017
- AstraZeneca Pharmaceuticals LP v. Mylan Pharmaceuticals Inc.District Court, D. Delaware · 2010
- In Re Rosuvastatin Calcium Patent LitigationDistrict Court, D. Delaware · 2010
1 more not listed; retrieve them via the Exa API.